---
$id: https://graph.org.ai/products/commodity/51152004
$type: Product
source: UNSPSC
code: "51152004"
title: "Vecuronium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vecuronium

**UNSPSC Code**: 51152004
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic antagonist with the molecular formula C34H57N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5438723848, chemically known as 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate but generally known as vecuronium, which bears US NIH Compound Identifier 39764. European Medicines Agency schedules Vecuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05084MIG. World Health Organization schedules vecuronium in its Anatomical Therapeutic Chemical (ATC) Classification. VECURONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, VECURONIUM remains the US FDA Preferred Term for this commodity. Vecuronium bears US NLM identifiers UMLS ID C0242531 and NCI Concept Code C87317. SMILES: BR.O(C1C2(C(C3C(C4(C(CC3)CC(OC(=O)C)C(N3CCCCC3)C4)C)CC2)CC1[N]1(CCCCC1)C)C)C(=O)C.

